Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13343841 | 0.96 | L3MBTL1 (0.60) | L3MBTL1HTTMAPTLMNAMEN1 | |
| SCHEMBL2274136 | 0.82 | L3MBTL1 (0.51) | L3MBTL1HTTMAPTLMNAMEN1 | |
| SCHEMBL29619886 | 0.80 | TERT (0.60) | MAPTMEN1KMT2ATERTALDH1A1 | |
| SCHEMBL6366033 | 0.76 | TERT (0.60) | HTTMEN1KMT2ATERTNPC1 | |
| SCHEMBL1679969 | 0.76 | TERT (0.60) | MAPTMEN1KMT2ATERTALDH1A1 | |
| SCHEMBL14391457 | 0.76 | TERT (0.53) | MAPTMEN1KMT2ATERTAPEX1 | |
| SCHEMBL14030964 | 0.76 | TERT (0.53) | L3MBTL1MAPTLMNAMEN1KMT2A | |
| SCHEMBL2337498 | 0.75 | KMT2A (0.69) | L3MBTL1HTTMAPTLMNAMEN1 | |
| SCHEMBL19102201 | 0.74 | APEX1 (0.56) | MAPTMEN1KMT2ATERTNPC1 | |
| SCHEMBL6796256 | 0.74 | ALDH1A1 (0.78) | L3MBTL1HTTMAPTLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009924-A1 | Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives | HUANG HSU-SHAN (TW) | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009924-A1 | Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives | NFE2L2, NR2F2, TFAM | L3MBTL1 301/4885HTT 2117/4885MAPT 4766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.